Skip to main content

Cancer start-up Grail added one of Silicon Valley's best-known biotech VCs to its board

In the process of raising $1 billion for early cancer detection, start-up Grail has added venture capital veteran Brook Byers to board.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.